Strain identifier
BacDive ID: 14446
Type strain: 
Species: Staphylococcus aureus
Strain Designation: Oxford H
Strain history: CIP <- 1953, ATCC <- Merck & Co. Inc., 3R7089: strain Oxford H <- 1944, N. Heatley, Oxford, UK
NCBI tax ID(s): 1280 (species)
version 8.1 (current version)
General
@ref: 359
BacDive-ID: 14446
DSM-Number: 683
keywords: genome sequence, 16S sequence, Bacteria, facultative anaerobe, mesophilic, Gram-positive, human pathogen
description: Staphylococcus aureus Oxford H is a facultative anaerobe, mesophilic, Gram-positive human pathogen of the family Staphylococcaceae.
NCBI tax id
- NCBI tax id: 1280
- Matching level: species
strain history
| @ref | history |
|---|---|
| 359 | <- NCTC <- N.G. Heatley |
| 116576 | CIP <- 1953, ATCC <- Merck & Co. Inc., 3R7089: strain Oxford H <- 1944, N. Heatley, Oxford, UK |
doi: 10.13145/bacdive14446.20230509.8.1
Name and taxonomic classification
LPSN
- @ref: 20215
- description: domain/bacteria
- keyword: phylum/bacillota
- domain: Bacteria
- phylum: Bacillota
- class: Bacilli
- order: Caryophanales
- family: Staphylococcaceae
- genus: Staphylococcus
- species: Staphylococcus aureus
- full scientific name: Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980)
synonyms
- @ref: 20215
- synonym: Staphylococcus aureus subsp. anaerobius
@ref: 359
domain: Bacteria
phylum: Firmicutes
class: Bacilli
order: Bacillales
family: Staphylococcaceae
genus: Staphylococcus
species: Staphylococcus aureus
full scientific name: Staphylococcus aureus Rosenbach 1884
strain designation: Oxford H
type strain: no
Morphology
cell morphology
| @ref | gram stain | confidence | cell shape | motility |
|---|---|---|---|---|
| 69480 | positive | 100 | ||
| 116576 | negative | coccus-shaped | no |
colony morphology
| @ref | type of hemolysis | hemolysis ability | incubation period |
|---|---|---|---|
| 359 | beta | 1 | 1-2 days |
| 116576 | 1 |
Culture and growth conditions
culture medium
| @ref | name | growth | link | composition |
|---|---|---|---|---|
| 359 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | yes | https://mediadive.dsmz.de/medium/693 | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base |
| 359 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | yes | https://mediadive.dsmz.de/medium/92 | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| 41860 | MEDIUM 72- for trypto casein soja agar | yes | Distilled water make up to (1000.000 ml);Trypto casein soy agar (40.000 g) | |
| 116576 | CIP Medium 72 | yes | https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72 |
culture temp
| @ref | growth | type | temperature | range |
|---|---|---|---|---|
| 359 | positive | growth | 37 | mesophilic |
| 41860 | positive | growth | 30 | mesophilic |
| 116576 | positive | growth | 15-37 | |
| 116576 | no | growth | 45 | thermophilic |
Physiology and metabolism
oxygen tolerance
- @ref: 116576
- oxygen tolerance: facultative anaerobe
antibiogram
| @ref | medium | incubation temperature | incubation time | oxygen condition | Penicillin G | oxacillin | ampicillin | ticarcillin | mezlocillin | cefalotin | cefazolin | cefotaxime | aztreonam | imipenem | tetracycline | chloramphenicol | gentamycin | amikacin | vancomycin | erythromycin | lincomycin | ofloxacin | norfloxacin | colistin | pipemidic acid | nitrofurantoin | bacitracin | polymyxin b | kanamycin | neomycin | doxycycline | ceftriaxone | clindamycin | fosfomycin | moxifloxacin | linezolid | nystatin | quinupristin/dalfopristin | teicoplanin | piperacillin/tazobactam |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 359 | Mueller-Hinton Agar | 37 | 1 | aerob | 40 | 32 | 38 | 44-46 | 34 | 40 | 40 | 28 | 0 | 50 | 32 | 28-30 | 24 | 26 | 22 | 30-32 | 32 | 30 | 30 | 0 | 16 | 22-24 | 18 | 8 | 24 | 22 | 32 | 28 | 34 | 30-32 | 32 | 34 | 0 | 28-30 | 18 | 34-36 |
| 359 | Mueller-Hinton Agar | 37 | 28-30 | 24-26 | 30 | 34 | 26 | 30 | 30 | 20 | 0 | 38 | 18 | 16 | 16 | 14 | 12 | 18 | 16 | 18 | 20 | 0 | 8 | 18 | 10 | 6 | 18 | 16 | 18 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | ||
| 359 | Mueller-Hinton Agar | 37 | 40 | 32 | 36 | 44 | 32 | 40 | 36 | 30 | 0 | >50 | 36 | 32-34 | 26 | 26 | 20-22 | 32 | 32 | 30 | 30 | 0 | 14 | 24-26 | 18-20 | 8 | 28 | 24 | 36-38 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. |
spore formation
| @ref | spore formation | confidence |
|---|---|---|
| 69481 | no | 97 |
| 69480 | no | 99.894 |
metabolite utilization
| @ref | Chebi-ID | metabolite | utilization activity | kind of utilization tested |
|---|---|---|---|---|
| 116576 | 17632 | nitrate | + | reduction |
| 116576 | 16301 | nitrite | + | reduction |
| 116576 | 35020 | tributyrin | + | hydrolysis |
| 68375 | 16199 | urea | + | hydrolysis |
| 68375 | 29016 | arginine | + | hydrolysis |
| 68375 | 18257 | ornithine | - | degradation |
| 68375 | 4853 | esculin | - | hydrolysis |
| 68375 | 17634 | D-glucose | + | fermentation |
| 68375 | 15824 | D-fructose | + | fermentation |
| 68375 | 16024 | D-mannose | + | fermentation |
| 68375 | 17306 | maltose | + | fermentation |
| 68375 | 17716 | lactose | + | fermentation |
| 68375 | 27082 | trehalose | + | fermentation |
| 68375 | 16899 | D-mannitol | + | fermentation |
| 68375 | 16634 | raffinose | - | fermentation |
| 68375 | 17057 | cellobiose | - | fermentation |
| 68375 | 17632 | nitrate | + | reduction |
| 68375 | 17992 | sucrose | + | fermentation |
| 68375 | 59640 | N-acetylglucosamine | + | fermentation |
| 68375 | 32528 | turanose | + | fermentation |
| 68375 | 22599 | arabinose | - | fermentation |
antibiotic resistance
- @ref: 116576
- metabolite: 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate)
- is antibiotic: yes
- is sensitive: no
- is resistant: yes
metabolite production
| @ref | Chebi-ID | metabolite | production |
|---|---|---|---|
| 68375 | 15688 | acetoin | yes |
| 116576 | 35581 | indole | no |
metabolite tests
| @ref | Chebi-ID | metabolite | voges-proskauer-test |
|---|---|---|---|
| 68375 | 15688 | acetoin | + |
| 116576 | 15688 | acetoin | + |
enzymes
| @ref | value | activity | ec |
|---|---|---|---|
| 359 | catalase | + | 1.11.1.6 |
| 359 | cytochrome-c oxidase | - | 1.9.3.1 |
| 68375 | beta-glucuronidase | - | 3.2.1.31 |
| 68375 | alkaline phosphatase | + | 3.1.3.1 |
| 68375 | L-arginine arylamidase | - | |
| 68375 | beta-galactosidase | - | 3.2.1.23 |
| 68375 | beta-glucosidase | - | 3.2.1.21 |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 |
| 68375 | arginine dihydrolase | + | 3.5.3.6 |
| 68375 | urease | + | 3.5.1.5 |
| 116576 | oxidase | - | |
| 116576 | beta-galactosidase | + | 3.2.1.23 |
| 116576 | alcohol dehydrogenase | + | 1.1.1.1 |
| 116576 | gelatinase | +/- | |
| 116576 | DNase | + | |
| 116576 | catalase | + | 1.11.1.6 |
| 116576 | coagulase | + | |
| 116576 | lecithinase | - | |
| 116576 | lipase | + | |
| 116576 | lysine decarboxylase | - | 4.1.1.18 |
| 116576 | ornithine decarboxylase | - | 4.1.1.17 |
| 116576 | urease | + | 3.5.1.5 |
| 68382 | alkaline phosphatase | + | 3.1.3.1 |
| 68382 | esterase (C 4) | + | |
| 68382 | esterase lipase (C 8) | + | |
| 68382 | lipase (C 14) | - | |
| 68382 | leucine arylamidase | - | 3.4.11.1 |
| 68382 | valine arylamidase | - | |
| 68382 | cystine arylamidase | - | 3.4.11.3 |
| 68382 | trypsin | - | 3.4.21.4 |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 |
| 68382 | acid phosphatase | + | 3.1.3.2 |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | |
| 68382 | alpha-galactosidase | - | 3.2.1.22 |
| 68382 | beta-galactosidase | - | 3.2.1.23 |
| 68382 | beta-glucuronidase | - | 3.2.1.31 |
| 68382 | alpha-glucosidase | + | 3.2.1.20 |
| 68382 | beta-glucosidase | - | 3.2.1.21 |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 |
| 68382 | alpha-mannosidase | - | 3.2.1.24 |
| 68382 | alpha-fucosidase | - | 3.2.1.51 |
API zym
| @ref | Control | Alkaline phosphatase | Esterase | Esterase Lipase | Lipase | Leucine arylamidase | Valine arylamidase | Cystine arylamidase | Trypsin | alpha- Chymotrypsin | Acid phosphatase | Naphthol-AS-BI-phosphohydrolase | alpha- Galactosidase | beta- Galactosidase | beta- Glucuronidase | alpha- Glucosidase | beta- Glucosidase | N-acetyl-beta- glucosaminidase | alpha- Mannosidase | alpha- Fucosidase |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116576 | - | + | + | + | - | - | - | - | - | - | + | + | - | - | - | + | - | - | - | - |
API ID32STA
| @ref | URE | ADH Arg | ODC | ESC | GLU | FRU | MNE | MAL | LAC | TRE | MAN | RAF | RIB | CEL | NIT | VP | beta GAL | ArgA | PAL | PyrA | NOVO | SAC | NAG | TUR | ARA | beta GUR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 359 | + | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | - | + | + | + | - | - |
| 359 | + | + | - | - | + | + | + | + | + | + | + | - | +/- | - | + | + | - | - | + | - | + | + | + | + | - | - |
| 359 | + | + | - | - | + | + | + | + | + | + | + | - | + | - | + | + | - | - | + | + | + | + | + | + | - | - |
API biotype100
| @ref | GLU | FRU | GAL | TRE | MNE | SBE | MEL | SAC | RAF | MTE | MAL | LAC | LTE | MbGa | MaGa | CEL | GEN | MbGu | ESC | RIB | ARA | XYL | PLE | RHA | FUC | MLZ | DARL | LARL | XLT | DUL | TAG | GLY | INO | MAN | MTL | TUR | SOR | ADO | HBG | LYX | ERY | MDG | 3MDG | SAT | MUC | LTAT | DTAT | MTAT | DMLT | LMLT | CATE | TATE | TTE | CIT | GRT | GAT | 2KG | 5KG | TRY | NAG | GNT | PAC | PAT | pOBE | QAT | GTE | mOBE | BAT | PPAT | CMT | TGE | BET | PCE | ABT | HIN | LAT | CAP | CYT | HIS | SUC | FUM | GRE | GYT | AVT | ETN | TTN | GLN | ITA | 3OBU | APT | GTT | PRO | DALA | LALA | SER | MNT | PROP | TYR | 2KT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116576 | + | + | + | + | + | - | + | - | - | + | + | + | + | - | - | - | - | + | - | + | - | - | - | - | - | - | - | - | - | - | - | + | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - | - | + | - | - | - | - | - | - | - | + | - | - | - | + | + | - | - | + | - | - | - | - |
Safety information
risk assessment
| @ref | pathogenicity human | pathogenicity animal | biosafety level | biosafety level comment |
|---|---|---|---|---|
| 359 | yes | yes | 2 | Risk group (German classification) |
| 116576 | 2 | Risk group (French classification) |
Sequence information
16S sequences
| @ref | description | accession | length | database | NCBI tax ID |
|---|---|---|---|---|---|
| 20218 | Staphylococcus aureus strain ATCC 9144 16S ribosomal RNA gene, partial sequence | GQ911563 | 804 | ena | 1280 |
| 20218 | Staphylococcus aureus subsp. aureus strain MTCC 96 16S ribosomal RNA gene, partial sequence | GQ925857 | 842 | ena | 46170 |
Genome sequences
| @ref | description | accession | assembly level | database | NCBI tax ID |
|---|---|---|---|---|---|
| 66792 | Staphylococcus aureus NCTC6571 | GCA_900457695 | contig | ncbi | 1280 |
| 66792 | Staphylococcus aureus strain NCTC6571 | 1280.18060 | wgs | patric | 1280 |
| 66792 | Staphylococcus aureus NCTC 6571-UB | GCA_023634625 | contig | ncbi | 1280 |
GC content
- @ref: 359
- GC-content: 32.0
Genome-based predictions
predictions
| trait | prediction | confidence | training_data |
|---|---|---|---|
| spore-forming | no | 97 | no |
| motile | no | 89.705 | no |
| gram-positive | yes | 88.335 | no |
| anaerobic | no | 99.544 | no |
| aerobic | yes | 89.979 | no |
| halophile | yes | 93.292 | no |
| spore-forming | no | 94.014 | no |
| thermophile | no | 99.589 | yes |
| glucose-util | yes | 89.607 | no |
| flagellated | no | 91.65 | no |
| glucose-ferment | yes | 84.752 | yes |
External links
@ref: 359
culture collection no.: DSM 683, ATCC 9144, CCM 2107, NCIB 6571, NRRL B-314, WDCM 00035, CCUG 1431, NCTC 6571, CIP 53.154, NRRL : B-314, NCIMB 6571, LMG 10640, CECT 59
straininfo link
- @ref: 83589
- straininfo: 66821
literature
| topic | Pubmed-ID | title | authors | journal | DOI | year | mesh | topic2 |
|---|---|---|---|---|---|---|---|---|
| Metabolism | 528972 | Transport and metabolism of bacilysin and other peptides by suspensions of Staphylococcus aureus. | Perry D, Abraham EP | J Gen Microbiol | 10.1099/00221287-115-1-213 | 1979 | Amino Acids/metabolism, Anti-Bacterial Agents/*metabolism/pharmacology, Biological Transport, Cell Wall/metabolism, Dipeptides/*metabolism, Drug Resistance, Microbial, Glycine/metabolism, Kinetics, Staphylococcus aureus/drug effects/*metabolism | Enzymology |
| Pathogenicity | 1029772 | Cold-sensitive variants of Staphylococcus aureus and their stimulation by penicillins and cephalosporins. | Annear DI, Grubb WB | Microbios | 1976 | Cephaloridine/pharmacology, Cephalosporins/*pharmacology, Cold Temperature, *Genetic Variation, Methicillin/pharmacology, Penicillins/*pharmacology, Staphylococcus/drug effects, Staphylococcus aureus/*growth & development | ||
| Pathogenicity | 1815103 | Immunoblotting and ligand blotting of envelope structures of Staphylococcus aureus grown under iron insufficiency and in a sub-minimal inhibitory concentration of penicillin G. | Domingue PA, Lambert PA, Brown MR | Microbios | 1991 | Animals, Antigens, Bacterial/analysis, Cell Membrane/chemistry/drug effects, Humans, Immune Sera/immunology, Immunoblotting, Iron/*metabolism, Ligands, Male, Penicillin G/*pharmacology, Phenotype, Rabbits, Staphylococcus aureus/*chemistry/drug effects/growth & development/immunology/ultrastructure | Phenotype | |
| Metabolism | 2515183 | Glutaraldehyde: its uptake by sporing and non-sporing bacteria, rubber, plastic and an endoscope. | Power EG, Russell AD | J Appl Bacteriol | 10.1111/j.1365-2672.1989.tb02502.x | 1989 | Aldehydes/*metabolism, Bacillus subtilis/*metabolism, Endoscopy, Escherichia coli/*metabolism, Glutaral/*metabolism, Polypropylenes, Rubber, Spores, Bacterial/metabolism, Staphylococcus aureus/*metabolism, Temperature | |
| Pathogenicity | 2759418 | Iron depletion alters surface-associated properties of Staphylococcus aureus and its association to human neutrophils in chemiluminescence. | Domingue PA, Lambert PA, Brown MR | FEMS Microbiol Lett | 10.1016/0378-1097(89)90429-1 | 1989 | Antigens, Surface, Cell Membrane/drug effects/immunology/metabolism, Humans, In Vitro Techniques, Iron/*pharmacology, Luminescent Measurements, Neutrophils/*immunology, Phagocytosis/drug effects, Staphylococcal Protein A/metabolism, Staphylococcus aureus/*drug effects/immunology/metabolism | Metabolism |
| 3182460 | Resistance studies with ofloxacin. | Felmingham D, Foxall P, O'Hare MD, Webb G, Ghosh G, Gruneberg RN | J Antimicrob Chemother | 10.1093/jac/22.supplement_c.27 | 1988 | Drug Resistance, Microbial, Mutation, Ofloxacin/*pharmacology | ||
| Cultivation | 4206088 | The relative susceptibility of four cephalosporins to a beta-lactamase from Bacillus cereus. | Russell AD, Furr JR | J Clin Pathol | 10.1136/jcp.26.8.599 | 1973 | Bacillus cereus/*enzymology, Cephalexin, Cephaloridine, *Cephalosporins, Cephalothin, Culture Media, In Vitro Techniques, Nitriles, Penicillin G, *Penicillinase, Spectrophotometry, Infrared, Staphylococcus/drug effects | Enzymology |
| Cultivation | 5489440 | Scanning electron microscopy of intact colonies of microorganisms. | Whittaker DK, Drucker DB | J Bacteriol | 10.1128/jb.104.2.902-909.1970 | 1970 | Candida/*cytology/growth & development, Culture Media, Freeze Drying, Gold, *Microscopy, Electron, Microscopy, Electron, Scanning, Palladium, Polysaccharides, Bacterial, Staphylococcus/*cytology/growth & development, Streptococcus/*cytology/growth & development | |
| Pathogenicity | 7007217 | Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence. | Williams AJ, Hastings MJ, Easmon CS, Cole PJ | Immunology | 1980 | Adult, Agammaglobulinemia/immunology, Cells, Cultured, Chelating Agents/pharmacology, Humans, Luminescent Measurements, Neutrophils/immunology, Opsonin Proteins/*immunology, *Phagocytosis, Photometry/methods, Saccharomyces cerevisiae, Temperature, Zymosan | Enzymology | |
| 7175730 | Determination of sodium fusidate and fusidic acid in dosage forms by high-performance liquid chromatography and a microbiological method. | Hikal AH, Shibl A, El-Hoofy S | J Pharm Sci | 10.1002/jps.2600711130 | 1982 | Biological Assay, Chromatography, High Pressure Liquid/methods, Fusidic Acid/*analysis, Ointments/analysis, Suspensions/analysis, Tablets/analysis | ||
| Metabolism | 7328406 | Peptide transport in Staphylococcus aureus. | Perry D | J Gen Microbiol | 10.1099/00221287-124-2-425 | 1981 | Agar, Biological Transport, Diffusion, Dipeptides/metabolism, Peptides/*metabolism, Staphylococcus aureus/*metabolism | |
| Enzymology | 7522262 | Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. | Kerr J | J Infect | 10.1016/s0163-4453(94)91943-7 | 1994 | *Antibiosis, Burkholderia cepacia/isolation & purification/*physiology, Candida/*growth & development, Cystic Fibrosis/*microbiology, Humans, Pseudomonas aeruginosa/isolation & purification/*physiology, Sputum/microbiology, Yeasts/growth & development | Phylogeny |
| Pathogenicity | 7966221 | Antibiogram-resistogram typing scheme for methicillin-resistant Staphylococcus aureus. | Rossney AS, Coleman DC, Keane CT | J Med Microbiol | 10.1099/00222615-41-6-430 | 1994 | Anti-Bacterial Agents/*pharmacology, Bacteriophage Typing, DNA, Bacterial/analysis, Humans, *Methicillin Resistance, Microbial Sensitivity Tests, Plasmids, Reproducibility of Results, Staphylococcus aureus/*classification/drug effects | Phylogeny |
| Pathogenicity | 8233637 | [Experimental study of the antibacterial activity of cloth impregnated with a disinfectant solution]. | Poinsot C, Blanc G, Garcin F, Joly B | Pathol Biol (Paris) | 1993 | *Bedding and Linens, Disinfectants/*pharmacology, Enterococcus/*drug effects, Escherichia coli/drug effects, In Vitro Techniques, Pseudomonas aeruginosa/*drug effects, Staphylococcus aureus/*drug effects, Water | ||
| Pathogenicity | 8262862 | Antimicrobial susceptibility testing of enterococci: results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology. | Snell JJ, Brown DF, Perry SF, George R | J Antimicrob Chemother | 10.1093/jac/32.3.401 | 1993 | Ampicillin Resistance, Anti-Bacterial Agents/*pharmacology, Enterococcus/*drug effects, Enterococcus faecalis/drug effects, Enterococcus faecium/drug effects, Gentamicins/pharmacology, Humans, Microbial Sensitivity Tests/*standards, Penicillin Resistance, Quality Assurance, Health Care, United Kingdom, Vancomycin/pharmacology | |
| Pathogenicity | 8405933 | An inexpensive infrared growth sensor array for detection of bacterial antibiotic susceptibility. | Mason DJ, Lloyd AL, Lloyd D | FEMS Microbiol Lett | 10.1111/j.1574-6968.1993.tb06394.x | 1993 | Ampicillin/pharmacology, Bacteria/*drug effects/isolation & purification, Ciprofloxacin/pharmacology, Escherichia coli/drug effects, Evaluation Studies as Topic, Gentamicins/pharmacology, Humans, Infrared Rays, Microbial Sensitivity Tests/*instrumentation, Penicillins/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects | Enzymology |
| Pathogenicity | 8586791 | Contamination of multi-use closed tracheal suction catheters: an in-vitro study. | Webb CH, Hogg GM | J Hosp Infect | 10.1016/0195-6701(95)90069-1 | 1995 | Bacteria/*isolation & purification, Catheterization/*instrumentation, *Equipment Contamination, Equipment Design, Humans, Intubation, Intratracheal, Respiration, Artificial, Suction/*instrumentation | Enzymology |
| Phenotype | 8636968 | True identity of control Staphylococcus aureus strains and their performance in the tube coagulase test. | Wilcox MH, Walker C, Winstanley TG, Limb DI | J Med Microbiol | 10.1099/00222615-44-6-496 | 1996 | Anti-Bacterial Agents/pharmacology, Bacterial Typing Techniques/standards, Bacteriophage Typing, Coagulase/*biosynthesis, Microbial Sensitivity Tests, Phenotype, Reference Standards, Staphylococcus aureus/classification/drug effects/enzymology/*isolation & purification | Enzymology |
| Pathogenicity | 8918956 | Inhibition of growth of fungi pathogenic to man by Stenotrophomonas maltophilia. | Kerr JR | J Med Microbiol | 10.1099/00222615-45-5-380 | 1996 | Aspergillus fumigatus/*growth & development, Candida/*growth & development, Escherichia coli/physiology, Haemophilus influenzae/physiology, Humans, Pseudomonas/*physiology, Staphylococcus aureus/physiology, Xanthomonas/*physiology | |
| Pathogenicity | 8997462 | Clinical investigation of topical antimicrobials in healthy volunteers. | Langford JH, Benrimoj S | Ann Pharmacother | 10.1177/106002809703100104 | 1997 | Administration, Topical, Adult, Anti-Bacterial Agents/administration & dosage/*pharmacology, Anti-Infective Agents, Local/administration & dosage/*pharmacology, Bacitracin/administration & dosage/*pharmacology, Cetrimonium, Cetrimonium Compounds/administration & dosage/*pharmacology, Female, Gels, Humans, Male, Microbial Sensitivity Tests, Polymyxin B/administration & dosage/*pharmacology, Random Allocation, Skin/drug effects, Staphylococcus aureus/*drug effects | |
| Pathogenicity | 9053565 | Evaluation of variable parameters in neutrophil function test using chemiluminescence assay. | Noah RM, Jais MR, Noh LM | Malays J Pathol | 1994 | Biological Assay/*methods, Evaluation Studies as Topic, Humans, Luminescent Measurements, Neutrophils/*physiology, Phagocytosis/*physiology | ||
| Pathogenicity | 9069554 | External quality assessment of the serum bactericidal test: results of a methodology/interpretation questionnaire. | MacGowan A, McMullin C, James P, Bowker K, Reeves D, White L | J Antimicrob Chemother | 10.1093/jac/39.2.277 | 1997 | *Bacteriological Techniques, *Blood Bactericidal Activity, Humans, Laboratories, Penicillin Resistance | |
| Stress | 9249207 | A flow cytometric study of antibiotic-induced damage and evaluation as a rapid antibiotic susceptibility test for methicillin-resistant Staphylococcus aureus. | Suller MT, Stark JM, Lloyd D | J Antimicrob Chemother | 10.1093/jac/40.1.77 | 1997 | Anti-Bacterial Agents/*pharmacology, Barbiturates/chemistry, Flow Cytometry/*methods, Gramicidin/pharmacology, Hot Temperature, Isoxazoles/chemistry, Methicillin/pharmacology, *Methicillin Resistance, Microbial Sensitivity Tests/*methods, Penicillin G/pharmacology, Reproducibility of Results, Staphylococcus aureus/*drug effects/physiology, Vancomycin/pharmacology | Pathogenicity |
| Enzymology | 9258363 | The chemistry of pseudomonic acid. 18. Heterocyclic replacement of the alpha,beta-unsaturated ester: synthesis, molecular modeling, and antibacterial activity. | Brown P, Best DJ, Broom NJ, Cassels R, O'Hanlon PJ, Mitchell TJ, Osborne NF, Wilson JM | J Med Chem | 10.1021/jm960738k | 1997 | Anti-Bacterial Agents/*chemical synthesis/pharmacology, Enzyme Inhibitors/*chemical synthesis/pharmacology, Isoleucine-tRNA Ligase/*antagonists & inhibitors, Microbial Sensitivity Tests, Models, Molecular, Mupirocin/analogs & derivatives/*chemistry/pharmacology, Spectrophotometry, Infrared, Staphylococcus aureus/drug effects/enzymology, Static Electricity, Structure-Activity Relationship | Pathogenicity |
| Pathogenicity | 9593149 | Flow cytometric assessment of the postantibiotic effect of methicillin on Staphylococcus aureus. | Suller MT, Lloyd D | Antimicrob Agents Chemother | 10.1128/AAC.42.5.1195 | 1998 | Colony Count, Microbial, Flow Cytometry/*methods, Methicillin/*pharmacology, Penicillins/*pharmacology, Staphylococcus aureus/cytology/*drug effects | |
| Pathogenicity | 9848440 | Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin. | Palepou MF, Johnson AP, Cookson BD, Beattie H, Charlett A, Woodford N | J Antimicrob Chemother | 10.1093/jac/42.5.577 | 1998 | Anti-Bacterial Agents/*pharmacology, Drug Resistance, Microbial/genetics, Evaluation Studies as Topic, Genes, Bacterial, Humans, Microbial Sensitivity Tests/*methods, Mupirocin/*pharmacology, Polymerase Chain Reaction, Staphylococcal Infections/microbiology, Staphylococcus aureus/*drug effects/genetics/isolation & purification | Enzymology |
| Enzymology | 10398558 | Evaluation of two methods for monitoring surface cleanliness-ATP bioluminescence and traditional hygiene swabbing. | Davidson CA, Griffith CJ, Peters AC, Fielding LM | Luminescence | 10.1002/(SICI)1522-7243(199901/02)14:1<33::AID-BIO514>3.0.CO;2-I | 1999 | Adenosine Triphosphate/*analysis, Environmental Monitoring/*methods, Escherichia coli/*isolation & purification, *Food Microbiology, *Hygiene, *Luminescence, Sensitivity and Specificity, Staphylococcus aureus/*isolation & purification | Phylogeny |
| Pathogenicity | 10456152 | Plasmid profiles of multiple drug resistant local strains of Staphylococcus aureus. | Adeleke OE, Odelola HA | Afr J Med Med Sci | 1997 | Cross Infection/drug therapy/*microbiology, DNA, Bacterial/*genetics, Electrophoresis, Agar Gel, Humans, Infection Control, Microbial Sensitivity Tests, Molecular Weight, Nigeria, R Factors/*genetics, Serotyping, Staphylococcal Infections/drug therapy/*microbiology, Staphylococcus aureus/*classification/enzymology/*genetics, beta-Lactam Resistance/*genetics, beta-Lactamases/analysis | Enzymology | |
| Stress | 10540242 | Heat transfer analysis of staphylococcus aureus on stainless steel with microwave radiation. | Yeo CB, Watson IA, Stewart-Tull DE, Koh VH | J Appl Microbiol | 10.1046/j.1365-2672.1999.00832.x | 1999 | *Hot Temperature, *Microwaves, Models, Theoretical, *Stainless Steel, Staphylococcus aureus/*radiation effects | |
| Pathogenicity | 11481290 | In vitro activity of fosfomycin in combination with various antistaphylococcal substances. | Grif K, Dierich MP, Pfaller K, Miglioli PA, Allerberger F | J Antimicrob Chemother | 10.1093/jac/48.2.209 | 2001 | Anti-Bacterial Agents/*pharmacology, Drug Combinations, Fosfomycin/*pharmacology, Humans, Microbial Sensitivity Tests/methods, Staphylococcus aureus/cytology/*drug effects, Staphylococcus epidermidis/cytology/*drug effects | |
| Pathogenicity | 11714006 | Antimicrobial activity of Mallotus oppositifolium extractives. | Ogundipe OO, Moody JO, Fakeye TO, Ladipo OB | Afr J Med Med Sci | 2000 | Biological Assay, Chemical Fractionation/methods, Chromatography, Thin Layer, Drug Evaluation, Preclinical, Fungi/*drug effects, Gram-Negative Bacteria/*drug effects, Gram-Positive Bacteria/*drug effects, Humans, *Medicine, African Traditional, Microbial Sensitivity Tests, Nigeria, Plant Extracts/chemistry, Plants, Medicinal/*chemistry/*physiology | ||
| Pathogenicity | 12019108 | Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. | Carson CF, Mee BJ, Riley TV | Antimicrob Agents Chemother | 10.1128/AAC.46.6.1914-1920.2002 | 2002 | Anti-Infective Agents, Local/*pharmacology, Colony Count, Microbial, Cytoplasm/drug effects/ultrastructure, Drug Resistance, Microbial, Electrolytes, Microbial Sensitivity Tests, Osmolar Concentration, Spectrophotometry, Ultraviolet, Staphylococcus aureus/chemistry/*drug effects/ultrastructure, Tea Tree Oil/*pharmacology, Time Factors | |
| Pathogenicity | 12680622 | In vitro antibacterial activity of Omani and African honey. | Al-Jabri AA, Nzeako B, Al Mahrooqi Z, Al Naqdy A, Nsanze H | Br J Biomed Sci | 10.1080/09674845.2003.11783668 | 2003 | Africa, Anti-Bacterial Agents/*pharmacology, Bacteria/*drug effects, Escherichia coli/drug effects, *Honey, Oman, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects | |
| Pathogenicity | 15555788 | The effect of essential oils on methicillin-resistant Staphylococcus aureus using a dressing model. | Edwards-Jones V, Buck R, Shawcross SG, Dawson MM, Dunn K | Burns | 10.1016/j.burns.2004.06.006 | 2004 | Anti-Bacterial Agents/*pharmacology, Anti-Infective Agents, Local/pharmacology, *Bandages, Drug Combinations, Humans, Lavandula, *Methicillin Resistance, Models, Biological, Oils, Volatile/*pharmacology, Pelargonium, Phytotherapy/methods, Plant Oils/pharmacology, Plant Preparations/pharmacology, Sesquiterpenes/pharmacology, Silver Sulfadiazine/pharmacology, Staphylococcus aureus/*drug effects/physiology, Tea Tree Oil/pharmacology | |
| Pathogenicity | 15577222 | Experimental analysis of antimicrobial action of dicyclomine hydrochloride. | Karaka P, Kumar KA, Basu LR, Dasgupta A, Ray R, Dastidar SG | Biol Pharm Bull | 10.1248/bpb.27.2010 | 2004 | Animals, Anti-Bacterial Agents/*pharmacology, Dicyclomine/*pharmacology, Gram-Negative Bacteria/*drug effects/physiology, Gram-Positive Bacteria/*drug effects/physiology, Male, Mice, Microbial Sensitivity Tests | |
| Cultivation | 15649007 | Evaluation of the neutralising capacity of bactec medium for some antibiotics. | Nzeako BC, Al-Qasabi SS | Br J Biomed Sci | 10.1080/09674845.2004.11732665 | 2004 | Amikacin/pharmacology, Amoxicillin/pharmacology, Amphotericin B/pharmacology, Anti-Bacterial Agents/*pharmacology, Bacteria/drug effects, Chloramphenicol/pharmacology, Culture Media, Gentamicins/pharmacology, Penicillins/pharmacology, Vancomycin/pharmacology | Pathogenicity |
| Pathogenicity | 15694658 | Synthesis of Schiff bases of 4-(4-aminophenyl)-morpholine as potential antimicrobial agents. | Panneerselvam P, Nair RR, Vijayalakshmi G, Subramanian EH, Sridhar SK | Eur J Med Chem | 10.1016/j.ejmech.2004.09.003 | 2005 | Anti-Bacterial Agents/*chemical synthesis/pharmacology, Antifungal Agents/chemical synthesis/pharmacology, Aspergillus niger/drug effects, Bacillus cereus/drug effects, Candida albicans/drug effects, Escherichia coli/drug effects, Microbial Sensitivity Tests, Micrococcus luteus/drug effects, Morpholines/*chemical synthesis/pharmacology, Nitrobenzenes/*chemical synthesis/pharmacology, Schiff Bases/*chemical synthesis/pharmacology, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Structure-Activity Relationship | |
| Enzymology | 15715132 | Sensitivity of Listeria species, recovered from indigenous chickens to antibiotics and disinfectants. | Njagi LW, Mbuthia PG, Bebora LC, Nyaga PN, Minga U, Olsen JE | East Afr Med J | 10.4314/eamj.v81i10.9237 | 2004 | Animals, Anti-Bacterial Agents/*pharmacology, Chickens/*microbiology, Disinfectants/*pharmacology, Drug Resistance, Multiple, Bacterial, Listeria/*drug effects/isolation & purification | Phylogeny |
| Pathogenicity | 15985350 | Detection of galangin-induced cytoplasmic membrane damage in Staphylococcus aureus by measuring potassium loss. | Cushnie TP, Lamb AJ | J Ethnopharmacol | 10.1016/j.jep.2005.04.014 | 2005 | Anti-Bacterial Agents/*pharmacology, Cell Membrane/*drug effects, Flavonoids/*pharmacology, Microbial Sensitivity Tests, Novobiocin/pharmacology, Penicillin G/pharmacology, Potassium/*metabolism, Staphylococcus aureus/*drug effects/metabolism | Metabolism |
| Metabolism | 16304175 | Beta-lactam resistance in Staphylococcus aureus cells that do not require a cell wall for integrity. | Fuller E, Elmer C, Nattress F, Ellis R, Horne G, Cook P, Fawcett T | Antimicrob Agents Chemother | 10.1128/AAC.49.12.5075-5080.2005 | 2005 | Bacterial Proteins, Cell Wall/metabolism/*physiology, Penicillin Resistance/*physiology, Penicillin-Binding Proteins, Staphylococcus aureus/*drug effects/physiology/ultrastructure, beta-Lactams/*pharmacology | Pathogenicity |
| Pathogenicity | 16963212 | Lunacridine from Lunasia amara is a DNA intercalating topoisomerase II inhibitor. | Prescott TA, Sadler IH, Kiapranis R, Maciver SK | J Ethnopharmacol | 10.1016/j.jep.2006.07.036 | 2006 | Anti-Bacterial Agents/pharmacology, Caspases/drug effects/metabolism, Cell Survival/drug effects, Drug Evaluation, Preclinical/methods, Enzyme Inhibitors/*pharmacology, HeLa Cells, Humans, Intercalating Agents/*pharmacology, Microbial Sensitivity Tests, Plant Bark/chemistry, Quinolines/pharmacology, Rutaceae/*chemistry, Staphylococcus aureus/drug effects, Streptococcus pneumoniae/drug effects, *Topoisomerase II Inhibitors | Metabolism |
| Pathogenicity | 17310119 | Development of in vitro antimicrobial resistance in bacteria exposed to residue level exposures of antimicrobial drugs, pesticides and veterinary drugs. | Kleiner DK, Katz SE, Ward PM | Chemotherapy | 10.1159/000100012 | 2007 | Anti-Bacterial Agents/*pharmacology, Drug Interactions, Drug Resistance, Multiple, Bacterial, Microbial Sensitivity Tests, Pesticides/*pharmacology, Staphylococcus aureus/*drug effects/growth & development, Veterinary Drugs/*pharmacology | |
| Genetics | 17314375 | Occurrence of ssl genes in isolates of Staphylococcus aureus from animal infection. | Smyth DS, Meaney WJ, Hartigan PJ, Smyth CJ | J Med Microbiol | 10.1099/jmm.0.46878-0 | 2007 | Animals, Blotting, Southern, Cattle, Chickens, DNA Fingerprinting, DNA Primers, DNA, Bacterial/genetics, Gene Dosage, *Genes, Bacterial, Genomic Islands, Genotype, Goats, Humans, Polymerase Chain Reaction/methods, Polymorphism, Restriction Fragment Length, Rabbits, Random Amplified Polymorphic DNA Technique, Sheep, Staphylococcal Infections/microbiology/*veterinary, Staphylococcus aureus/classification/*genetics/isolation & purification, *Synteny | Pathogenicity |
| Pathogenicity | 17953567 | Aggregation of Staphylococcus aureus following treatment with the antibacterial flavonol galangin. | Cushnie TP, Hamilton VE, Chapman DG, Taylor PW, Lamb AJ | J Appl Microbiol | 10.1111/j.1365-2672.2007.03393.x | 2007 | Bacterial Adhesion/drug effects, Colony Count, Microbial, Flavonoids/analysis/*pharmacology, Flavonols/*pharmacology, Helichrysum/chemistry, Plant Extracts, Propolis/chemistry, Staphylococcus aureus/*drug effects/physiology | |
| Pathogenicity | 18582911 | Flavonols and an oxychromonol from Piliostigma reticulatum. | Babajide OJ, Babajide OO, Daramola AO, Mabusela WT | Phytochemistry | 10.1016/j.phytochem.2008.05.003 | 2008 | Animals, Anti-Bacterial Agents/chemistry/pharmacology, Artemia/drug effects, Fabaceae/*chemistry, Flavonols/*chemistry/pharmacology, Magnetic Resonance Spectroscopy, Microbial Viability/drug effects, Molecular Structure, Structure-Activity Relationship | |
| Pathogenicity | 19419878 | Design, synthesis and biological investigation of certain pyrazole-3-carboxylic acid derivatives as novel carriers for nitric oxide. | Abdel-Hafez el-SM, Abuo-Rahma Gel-D, Abdel-Aziz M, Radwan MF, Farag HH | Bioorg Med Chem | 10.1016/j.bmc.2009.04.037 | 2009 | Animals, Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Anti-Inflammatory Agents/chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Carboxylic Acids/chemical synthesis/*chemistry/pharmacology, *Drug Design, Molecular Structure, Nitric Oxide/*chemistry/metabolism, Pyrazoles/chemical synthesis/*chemistry/pharmacology, Rats | Metabolism |
| Enzymology | 21521657 | Antibacterial activities of essential oils from eight Greek aromatic plants against clinical isolates of Staphylococcus aureus. | Alexopoulos A, Kimbaris AC, Plessas S, Mantzourani I, Theodoridou I, Stavropoulou E, Polissiou MG, Bezirtzoglou E | Anaerobe | 10.1016/j.anaerobe.2011.03.024 | 2011 | Anti-Bacterial Agents/isolation & purification/*pharmacology, Gas Chromatography-Mass Spectrometry, Greece, Humans, Microbial Sensitivity Tests, Oils, Volatile/chemistry/isolation & purification/*pharmacology, Plant Extracts/chemistry/isolation & purification/*pharmacology, Plants/*chemistry, Staphylococcal Infections/microbiology, Staphylococcus aureus/*drug effects/isolation & purification | Phylogeny |
| 22247864 | Synthesis and anti-microbial screening of novel schiff bases of 3-amino-2-methyl quinazolin 4-(3H)-one. | Saravanan G, Pannerselvam P, Prakash CR | J Adv Pharm Technol Res | 10.4103/0110-5558.72426 | 2010 | |||
| Pathogenicity | 22505440 | Susceptibility of community associated methicillin resistant Staphylococcus aureus isolated from faeces to antiseptics. | Akinkunmi EO, Lamikanra A | J Infect Dev Ctries | 10.3855/jidc.1609 | 2012 | Anti-Bacterial Agents/pharmacology, Anti-Infective Agents, Local/*pharmacology, Child, Preschool, Community-Acquired Infections/*microbiology, Feces/*microbiology, Humans, Methicillin-Resistant Staphylococcus aureus/*drug effects/isolation & purification, Microbial Sensitivity Tests, Staphylococcal Infections/*microbiology | Enzymology |
| Genetics | 23057159 | Exposure to clinical X-ray radiation does not alter antibiotic susceptibility or genotype profile in gram-negative and gram-positive clinical pathogens. | Hayashi K, Hirayama J, Goldsmith CE, Coulter WA, Millar BC, Dooley JS, Loughrey A, Rooney PJ, Matsuda M, Moore JE | Br J Biomed Sci | 2012 | Anti-Bacterial Agents/*pharmacology, Bacteria/drug effects/*genetics/*radiation effects, DNA, Bacterial/*genetics/*radiation effects, Dose-Response Relationship, Radiation, Drug Resistance, Bacterial/*genetics/*radiation effects, Genotype, Mutation/genetics/radiation effects, Radiation Dosage | Pathogenicity | |
| Pathogenicity | 23570001 | In vitro control of Staphylococcus aureus (NCTC 6571) and Escherichia coli (ATCC 25922) by Ricinus communis L. | Jeyaseelan EC, Jashothan PT | Asian Pac J Trop Biomed | 10.1016/S2221-1691(12)60216-0 | 2012 | Anti-Bacterial Agents/chemistry/*pharmacology, Escherichia coli/*drug effects, Microbial Sensitivity Tests, Phytochemicals/chemistry, Plant Extracts/chemistry/*pharmacology, Plant Leaves/chemistry, Ricinus/*chemistry, Staphylococcus aureus/*drug effects | |
| Pathogenicity | 23856977 | Convenient syntheses of cyanuric chloride-derived NHC ligands, their Ag(I) and Au(I) complexes and antimicrobial activity. | Almalioti F, MacDougall J, Hughes S, Hasson MM, Jenkins RL, Ward BD, Tizzard GJ, Coles SJ, Williams DW, Bamford S, Fallis IA, Dervisi A | Dalton Trans | 10.1039/c3dt51400e | 2013 | Anti-Infective Agents/*chemical synthesis/chemistry/pharmacology, Bacteria/drug effects, Candida albicans/drug effects, Coordination Complexes/*chemical synthesis/chemistry/pharmacology, Gold/*chemistry, Heterocyclic Compounds/chemistry, Imidazoles/chemistry, Ligands, Methane/*analogs & derivatives/chemistry, Silver/*chemistry, Triazines/*chemistry | |
| Pathogenicity | 24311881 | Antimicrobial and antiplasmodial activities of a quaternary compound from Ritchiea capparoides var. longipedicellata. | Taiwo BJ, Akinkunmi EO, Omisore N | Afr J Tradit Complement Altern Med | 10.4314/ajtcam.v10i6.23 | 2013 | Anti-Infective Agents/chemistry/*pharmacology, Antimalarials/chemistry/*pharmacology, Bacillus subtilis/drug effects, Capparaceae/*chemistry, Chromatography, Liquid, Escherichia coli/drug effects, Microbial Sensitivity Tests, Nigeria, Plant Extracts/chemistry/*pharmacology, Plant Leaves, Plant Roots, Plant Stems, Plasmodium/drug effects, Pseudomonas aeruginosa/drug effects, Quaternary Ammonium Compounds/*pharmacology, Staphylococcus aureus/drug effects | |
| Biotechnology | 25582133 | New platforms for multi-functional ocular lenses: engineering double-sided functionalized nano-coatings. | Mehta P, Justo L, Walsh S, Arshad MS, Wilson CG, O'Sullivan CK, Moghimi SM, Vizirianakis IS, Avgoustakis K, Fatouros DG, Ahmad Z | J Drug Target | 10.3109/1061186X.2014.1001395 | 2015 | Anti-Bacterial Agents/administration & dosage/pharmacology, Chemistry, Pharmaceutical/methods, Chloramphenicol/*administration & dosage/pharmacology, *Drug Delivery Systems, Excipients/chemistry, *Lenses, Intraocular, *Nanoparticles, Particle Size, Polymers/chemistry, Povidone/chemistry, Staphylococcus aureus/drug effects, Temperature | Pathogenicity |
| Pathogenicity | 25738966 | Sophorolipid biosurfactants: Possible uses as antibacterial and antibiofilm agent. | Diaz De Rienzo MA, Banat IM, Dolman B, Winterburn J, Martin PJ | N Biotechnol | 10.1016/j.nbt.2015.02.009 | 2015 | Anti-Bacterial Agents/chemistry/*pharmacology, Bacterial Physiological Phenomena/*drug effects, Biofilms/*drug effects/*growth & development, Cell Adhesion/drug effects/physiology, Cell Survival/drug effects, Glycolipids/chemistry/*pharmacology, Surface-Active Agents/chemistry/*pharmacology | |
| Pathogenicity | 26256176 | Development of bio-composites with novel characteristics: Evaluation of phenol-induced antibacterial, biocompatible and biodegradable behaviours. | Iqbal HM, Kyazze G, Locke IC, Tron T, Keshavarz T | Carbohydr Polym | 10.1016/j.carbpol.2015.05.046 | 2015 | Anti-Bacterial Agents/*pharmacology, Bacteria/drug effects, Biocompatible Materials/*pharmacology, Biodegradation, Environmental/drug effects, Cell Adhesion/drug effects, Cell Line, Cell Shape/drug effects, Cell Survival/drug effects, Gallic Acid/chemistry, Humans, Microbial Sensitivity Tests, Phenol/*pharmacology, Soil, Spectroscopy, Fourier Transform Infrared | |
| Pathogenicity | 26598715 | Antibacterial properties of biosurfactants against selected Gram-positive and -negative bacteria. | Diaz De Rienzo MA, Stevenson P, Marchant R, Banat IM | FEMS Microbiol Lett | 10.1093/femsle/fnv224 | 2015 | Anti-Bacterial Agents/*pharmacology, Biofilms/drug effects, Gram-Negative Bacteria/*drug effects/growth & development/physiology, Gram-Positive Bacteria/*drug effects/growth & development/physiology, Microbial Sensitivity Tests, Surface-Active Agents/*pharmacology | |
| Pathogenicity | 26674158 | Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains. | Pereira F, Madureira AM, Sancha S, Mulhovo S, Luo X, Duarte A, Ferreira MJ | J Ethnopharmacol | 10.1016/j.jep.2015.12.009 | 2015 | Annonaceae/*chemistry, Anti-Bacterial Agents/*chemistry/*pharmacology, Methicillin-Resistant Staphylococcus aureus/*drug effects, Microbial Sensitivity Tests/methods, Plant Extracts/chemistry/pharmacology, Plants, Medicinal/*chemistry, Staphylococcus aureus/*drug effects, Vancomycin/pharmacology | |
| Pathogenicity | 26825819 | Effect of biosurfactants on Pseudomonas aeruginosa and Staphylococcus aureus biofilms in a BioFlux channel. | Diaz De Rienzo MA, Stevenson PS, Marchant R, Banat IM | Appl Microbiol Biotechnol | 10.1007/s00253-016-7310-5 | 2016 | Anti-Bacterial Agents/analysis/*pharmacology, Biofilms/*drug effects, Caprylates/analysis/pharmacology, Glycolipids/analysis/pharmacology, Pseudomonas aeruginosa/*drug effects/physiology, Staphylococcus aureus/*drug effects/physiology, Surface-Active Agents/analysis/*pharmacology | |
| Pathogenicity | 27885572 | Improving tribological and anti-bacterial properties of titanium external fixation pins through surface ceramic conversion. | Dong H, Mukinay T, Li M, Hood R, Soo SL, Cockshott S, Sammons R, Li X | J Mater Sci Mater Med | 10.1007/s10856-016-5816-0 | 2016 | Alloys, Anti-Bacterial Agents/*administration & dosage, Biomechanical Phenomena, *Bone Nails, Ceramics/*chemistry, Coated Materials, Biocompatible, External Fixators, Materials Testing, Microbial Sensitivity Tests, Microscopy, Electron, Scanning, Microscopy, Electron, Transmission, Staphylococcal Infections/*drug therapy, Staphylococcus aureus/drug effects, Temperature, Titanium/*chemistry, X-Ray Diffraction | |
| Pathogenicity | 28543603 | Silver nanoparticles: Antimicrobial activity, cytotoxicity, and synergism with N-acetyl cysteine. | Hamed S, Emara M, Shawky RM, El-Domany RA, Youssef T | J Basic Microbiol | 10.1002/jobm.201700087 | 2017 | Acetylcysteine/*pharmacology, Anti-Infective Agents/*pharmacology, Candida albicans/drug effects/ultrastructure, Cell Line, Drug Resistance, Bacterial, Drug Resistance, Fungal, Drug Synergism, Escherichia coli/drug effects/ultrastructure, Humans, *Metal Nanoparticles/chemistry/toxicity, Microbial Sensitivity Tests, Muramic Acids/metabolism, Oxidoreductases/metabolism, Pseudomonas aeruginosa/drug effects/ultrastructure, Silver/metabolism/*pharmacology/toxicity, Staphylococcus aureus/drug effects/ultrastructure | Metabolism |
| Pathogenicity | 28747232 | Development of an accumulation assay and evaluation of the effects of efflux pump inhibitors on the retention of chlorhexidine digluconate in Pseudomonas aeruginosa and Staphylococcus aureus. | Mombeshora M, Mukanganyama S | BMC Res Notes | 10.1186/s13104-017-2637-2 | 2017 | ATP-Binding Cassette Transporters/*antagonists & inhibitors, Anti-Infective Agents, Local/*pharmacology, Chlorhexidine/*analogs & derivatives/pharmacology, Cross Infection/*prevention & control, Microbial Sensitivity Tests, Protein Synthesis Inhibitors/*pharmacology, Pseudomonas aeruginosa/*drug effects, Reserpine/*pharmacology, Staphylococcus aureus/*drug effects | |
| Enzymology | 28969677 | Chemical composition, anti-biofilm activity and potential cytotoxic effect on cancer cells of Rosmarinus officinalis L. essential oil from Tunisia. | Jardak M, Elloumi-Mseddi J, Aifa S, Mnif S | Lipids Health Dis | 10.1186/s12944-017-0580-9 | 2017 | Anti-Bacterial Agents/chemistry/isolation & purification/*pharmacology, Bicyclic Monoterpenes, Biofilms/*drug effects/growth & development, Bridged Bicyclo Compounds/isolation & purification, Camphor/isolation & purification, Cell Survival/drug effects, Cyclohexane Monoterpenes, Cyclohexanols/isolation & purification, Eucalyptol, Gas Chromatography-Mass Spectrometry, HeLa Cells, Humans, MCF-7 Cells, Microbial Sensitivity Tests, Monoterpenes/isolation & purification, Oils, Volatile/chemistry/isolation & purification/*pharmacology, Plants, Medicinal, Polycyclic Sesquiterpenes, Rosmarinus/*chemistry, Sesquiterpenes/isolation & purification, Staphylococcus aureus/*drug effects/growth & development, Staphylococcus epidermidis/*drug effects/growth & development, Terpenes/isolation & purification, Tunisia | Phylogeny |
| 31084085 | Resistance Development Potential of Antibiotic/Antimicrobial Residue Levels Designated as "Safe Levels". | Brady MS, White N, Katz SE | J Food Prot | 10.4315/0362-028X-56.3.229 | 1993 | |||
| 31139383 | Evaluation of Thymus vulgaris and Thymbra spicata essential oils and plant extracts for chemical composition, antioxidant, and antimicrobial properties. | Gedikoglu A, Sokmen M, Civit A | Food Sci Nutr | 10.1002/fsn3.1007 | 2019 | |||
| Pathogenicity | 31195587 | In Vitro Enhancement of Antibiotic Resistance Development-Interaction of Residue Levels of Pesticides and Antibiotics (dagger). | Bordas AC, Brady MS, Siewierski M, Katz SE | J Food Prot | 10.4315/0362-028X-60.5.531 | 1997 | ||
| Enzymology | 31769678 | Evidences of Biomimetic and Nonantibiotic Characteristics of the Zinc-Carboxymethyl Chitosan-Genipin Organometallic Complex and Its Biocompatibility Aspects. | Mishra AH, Mishra D | Biomacromolecules | 10.1021/acs.biomac.9b01391 | 2019 | Adhesives/*chemistry/pharmacokinetics, Biocompatible Materials/chemistry/*pharmacokinetics, Biomimetic Materials/chemistry/*pharmacokinetics, Biomimetics/methods, Cells, Cultured, Chitosan/*analogs & derivatives/chemistry/pharmacokinetics, Dental Pulp/drug effects/metabolism, Erythrocytes/drug effects/metabolism, Humans, Iridoids/*chemistry/pharmacokinetics, Materials Testing/methods, Microbial Sensitivity Tests/methods, Tissue Scaffolds, Zinc/*chemistry/pharmacokinetics | Pathogenicity |
| 32091239 | Lawsozaheer, a new chromone produced by an endophytic fungus Paecilomyces variotii isolated from Lawsonia Alba Lam. inhibits the growth of Staphylococcus aureus. | Abbas Z, Siddiqui BS, Shahzad S, Sattar S, Begum S, Batool A, Choudhary MI | Nat Prod Res | 10.1080/14786419.2020.1729148 | 2020 | Byssochlamys, Chromones/pharmacology, *Fusarium, *Paecilomyces, Staphylococcus aureus | ||
| 33732047 | Inhibition of biofilm formation by alpha-mangostin loaded nanoparticles against Staphylococcus aureus. | Nguyen PTM, Nguyen MTH, Bolhuis A | Saudi J Biol Sci | 10.1016/j.sjbs.2020.11.061 | 2020 | |||
| 33953751 | The Antibacterial Activity of Crude Extracts of Secondary Metabolites from Bacterial Endophytes Associated with Dicoma anomala. | Makuwa SC, Serepa-Dlamini MH | Int J Microbiol | 10.1155/2021/8812043 | 2021 | |||
| Enzymology | 34477502 | Molecular Cloning, Functional and Biophysical Characterization of an Antimicrobial Peptide from Rhizosphere Soil. | Boparai JK, Nancy, Sharma PK | Protein Pept Lett | 10.2174/0929866528666210903162137 | 2021 | *Anti-Bacterial Agents/biosynthesis/chemistry/pharmacology, *Antimicrobial Peptides/biosynthesis/chemistry/genetics/pharmacokinetics, Bacteria/*growth & development, *Cloning, Molecular, Humans, *Metagenome, *Rhizosphere | Pathogenicity |
| 34497647 | Chemical and Antimicrobial Analyses of Juniperus chinensis and Juniperus seravschanica Essential Oils and Comparison with Their Methanolic Crude Extracts. | Khamis AS, Chai LC | Int J Anal Chem | 10.1155/2021/9937522 | 2021 | |||
| 34827362 | A Systematic Study of the Antibacterial Activity of Basidiomycota Crude Extracts. | Clericuzio M, Bivona M, Gamalero E, Bona E, Novello G, Massa N, Dovana F, Marengo E, Robotti E | Antibiotics (Basel) | 10.3390/antibiotics10111424 | 2021 | |||
| 35598875 | Cutibacterium acnes biofilm forming clinical isolates modify the formation and structure of Staphylococcus aureus biofilms, increasing their susceptibility to antibiotics. | Abbott C, Grout E, Morris T, Brown HL | Anaerobe | 10.1016/j.anaerobe.2022.102580 | 2022 | |||
| Genetics | 35997498 | Draft Genome Sequence of a Multiple Antibiotic Resistant Staphylococcus aureus NCTC 6571-UB Laboratory Strain. | Norton P, Chua KO, Katsikogianni M, Thornton MJ, Chan KG, Chang CY | Microbiol Resour Announc | 10.1128/mra.00448-22 | 2022 | Pathogenicity |
Reference
| @id | authors | catalogue | doi/url | title | journal | pubmed |
|---|---|---|---|---|---|---|
| 359 | Curators of the DSMZ | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 683) | https://www.dsmz.de/collection/catalogue/details/culture/DSM-683 | |||
| 20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M. | 10.1099/ijsem.0.004332 | List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ | |||
| 20218 | Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P. | 10.1016/j.syapm.2013.11.002 | StrainInfo introduces electronic passports for microorganisms. | Syst Appl Microbiol. 37: 42-50 2014 | 24321274 | |
| 41860 | Curators of the CIP | https://brclims.pasteur.fr/brcWeb/souche/detail/1/16978 | ||||
| 66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |||
| 68375 | Automatically annotated from API ID32STA | |||||
| 68382 | Automatically annotated from API zym | |||||
| 69480 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |||
| 69481 | Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch | 10.21203/rs.3.rs-2527258/v1 | Predictions based on the model GenomeNet Sporulation v. 1 | |||
| 83589 | Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J. | 10.60712/SI-ID66821.1 | StrainInfo: A central database for resolving microbial strain identifiers | |||
| 116576 | Curators of the CIP | Collection of Institut Pasteur (CIP 53.154) | https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2053.154 |